The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels

Gynecologic Oncology

Volumn 101, Issue 2, 2006, Pages 305-310

  Zhou, Chunxiao ^a   Bae Jump, Victoria L ^a   Whang, Young E ^a   Gehrig, Paola A ^a   Boggess, John F ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Endometrial cancer; PTEN; Telomerase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADENOVIRUS VECTOR; LIPID; MESSENGER RNA; MUTANT PROTEIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B BETA; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; WILD TYPE;

ADENOVIRIDAE; CELL GROWTH PROCESSES; CHROMONES; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; ENZYME INHIBITORS; FEMALE; HUMANS; MORPHOLINES; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TELOMERASE; TRANSDUCTION, GENETIC;

EID: 33646398872     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.10.038     Document Type: Article

References (24)

1. Mutter G.L., Lin M.C., Fitzgerald J.T., Kum J.B., Baak J.P., Lees J.A., et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J. Natl. Cancer Inst. 92 11 (2000) 924-930
2. Cantley L.C., and Neel B.G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. U. S. A. 96 8 (1999) 4240-4245
3. Yuan X.J., and Whang Y.E. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Oncogene 21 2 (2002) 319-327
4. Wu X., Senechal K., Neshat M.S., Whang Y.E., and Sawyers C.L. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. U. S. A. 95 26 (1998) 15587-15591
5. Cong Y.S., Wright W.E., and Shay J.W. Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 66 3 (2002) 407-425
6. Stewart S.A., and Weinberg R.A. Telomerase and human tumorigenesis. Semin. Cancer Biol. 10 6 (2000) 399-406
7. Williams C.D., Boggess J.F., LaMarque L.R., Meyer W.R., Murray M.J., Fritz M.A., et al. A prospective, randomized study of endometrial telomerase during the menstrual cycle. J. Clin. Endocrinol. Metab. 86 8 (2001) 3912-3917
8. Mutter G.L., Lin M.C., Fitzgerald J.T., Kum J.B., and Eng C. Changes in endometrial PTEN expression throughout the human menstrual cycle. J. Clin. Endocrinol. Metab. 85 6 (2000) 2334-2338
9. Kyo S., Kanaya T., Takakura M., Tanaka M., and Inoue M. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int. J. Cancer 80 1 (1999) 60-63
10. Lehner R., Enomoto T., McGregor J.A., Shroyer A.L., Haugen B.R., Pugazhenthi U., et al. Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium. Gynecol. Oncol. 84 1 (2002) 120-125
11. Maida Y., Kyo S., Kanaya T., Wang Z., Tanaka M., Yatabe N., et al. Is the telomerase assay useful for screening of endometrial lesions?. Int. J. Cancer 100 6 (2002) 714-718
12. Brien T.P., Kallakury B.V., Lowry C.V., Ambros R.A., Muraca P.J., Malfetano J.H., et al. Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res. 57 13 (1997) 2760-2764
13. Holt S.N.J., Woodring W.E., and Shay J.W. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods Cell Sci. 18 (1996) 237-248
14. Bieche I., Nogues C., Paradis V., Olivi M., Bedossa P., Lidereau R., et al. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin. Cancer Res. 6 2 (2000) 452-459
15. Zhou C., Gehrig P.A., Whang Y.E., and Boggess J.F. Rapamycin inhibits telomerase activity by decreasing the hTERT mRNA level in endometrial cancer cells. Mol. Cancer Ther. 2 8 (2003) 789-795
16. Tian X.X., Pang J.C., To S.S., and Ng H.K. Restoration of wild-type PTEN expression leads to apoptosis, induces differentiation, and reduces telomerase activity in human glioma cells. J. Neuropathol. Exp. Neurol. 58 5 (1999) 472-479
17. Kang S.S., Kwon T., Kwon D.Y., and Do S.I. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem. 274 19 (1999) 13085-13090
18. Jemal A., Ward E., Wu X., Martin H.J., McLaughlin C.C., and Thun M.J. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States. Cancer Epidemiol. Biomarkers Prev. 14 3 (2005) 590-595
19. Kyo S., Takakura M., Kohama T., and Inoue M. Telomerase activity in human endometrium. Cancer Res. 57 4 (1997) 610-614
20. Saito T., Schneider A., Martel N., Mizumoto H., Bulgay-Moerschel M., Kudo R., et al. Proliferation-associated regulation of telomerase activity in human endometrium and its potential implication in early cancer diagnosis. Biochem. Biophys. Res. Commun. 231 3 (1997) 610-614
21. Kyo S., Kanaya T., Ishikawa H., Ueno H., and Inoue M. Telomerase activity in gynecological tumors. Clin. Cancer Res. 2 12 (1996) 2023-2028
22. Kimura A., Ohmichi M., Kawagoe J., Kyo S., Mabuchi S., Takahashi T., et al. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene 23 26 (2004) 4505-4515
23. Misiti S., Nanni S., Fontemaggi G., Cong Y.S., Wen J., Hirte H.W., et al. Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol. Cell. Biol. 20 11 (2000) 3764-3771
24. Kyo S., Takakura M., Kanaya T., Zhuo W., Fujimoto K., Nishio Y., et al. Estrogen activates telomerase. Cancer Res. 59 23 (1999) 5917-5921